Yanchik Connealy Pamela has filed 31 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 15000 shares of Orchestra BioMed Holdings, Inc. ($OBIO) on August 07, 2025.
Activity breakdown: 6 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15000 | $0.00 | 48,711.0000 | 38,392,716 | 44.50% | 0.04% |
| June 24, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 12422 | $0.00 | 33,711.0000 | 38,235,409 | 58.35% | 0.03% |
| June 24, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Stock Option (Right to Buy) | 36797 | $0.00 | 36,797.0000 | 38,235,409 | 9999.99% | 0.10% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO & COO | A | Stock Option (Right to Buy) | 414163 | $0.98 | 414,163.0000 | 58,445,765 | 9999.99% | 0.71% |
| Dec. 23, 2024 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO & COO | A | Stock Option (Right to Buy) | 310000 | $0.00 | 310,000.0000 | 60,715,041 | 9999.99% | 0.51% |
| Nov. 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO & COO | P | Common Stock | 5450 | $2.00 | 2,314,886.0000 | 60,715,041 | 0.24% | 0.01% |
| Nov. 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO & COO | P | Common Stock | 83400 | $1.96 | 2,314,886.0000 | 60,715,041 | 3.74% | 0.14% |
| June 20, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Stock Option (Right to Buy) | 17068 | $0.00 | 17,068.0000 | 35,777,877 | 9999.99% | 0.05% |
| June 20, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5376 | $0.00 | 21,289.0000 | 35,777,877 | 33.78% | 0.02% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO & COO | A | Common Stock | 328710 | $0.00 | 1,110,293.0000 | 39,904,603 | 42.06% | 0.82% |
| Nov. 29, 2023 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO and COO | F | Common Stock | 36949 | $1.40 | 781,583.0000 | 0 | 4.51% | 0.00% |
| Sept. 28, 2023 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO and COO | P | Common Stock | 8000 | $1.87 | 818,532.0000 | 0 | 0.99% | 0.00% |
| Sept. 27, 2023 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO and COO | P | Common Stock | 6426 | $1.85 | 810,532.0000 | 0 | 0.80% | 0.00% |
| Sept. 25, 2023 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO and COO | P | Common Stock | 12000 | $1.67 | 804,106.0000 | 0 | 1.51% | 0.00% |
| Sept. 22, 2023 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO and COO | P | Common Stock | 5000 | $1.74 | 792,106.0000 | 0 | 0.64% | 0.00% |
| Sept. 7, 2023 | Pyxis Oncology, Inc. | $PYXS | Connealy Pamela Ann | CFO and COO | A | Common Stock | 187793 | $0.00 | 782,106.0000 | 0 | 31.60% | 0.00% |
| July 20, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 34,613,466 | 9999.99% | 0.05% |
| July 20, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 11667 | $0.00 | 15,913.0000 | 34,613,466 | 274.78% | 0.03% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Connealy Pamela Ann | Director | A | Nonstatutory Stock Option (Right to Buy) | 23250 | $0.00 | 23,250.0000 | 14,988,584 | 9999.99% | 0.16% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Yanchik Connealy Pamela | Director | A | Right to Receive Earnout Shares | 1516 | $0.00 | 1,516.0000 | 14,988,584 | 9999.99% | 0.01% |
| April 12, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Yanchik Connealy Pamela | Director | M | Right to Receive Earnout Shares | 758 | $0.00 | 758.0000 | 27,643,549 | 50.00% | 0.00% |
| April 12, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Yanchik Connealy Pamela | Director | M | Common Stock, par value $0.0001 per share ("Common Stock") | 758 | $0.00 | 4,246.0000 | 27,643,549 | 21.73% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Yanchik Connealy Pamela | CFO and COO | D | Stock Option (Right to buy) | 322265 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Yanchik Connealy Pamela | CFO and COO | A | Common Stock | 209803 | $0.00 | 594,313.0000 | 0 | 54.56% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Yanchik Connealy Pamela | CFO and COO | D | Stock Option (Right to buy) | 10304 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Yanchik Connealy Pamela | CFO and COO | A | Stock Option (Right to buy) | 322265 | $0.00 | 322,265.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Yanchik Connealy Pamela | CFO and COO | A | Stock Option (Right to buy) | 10304 | $0.00 | 10,304.0000 | 0 | 9999.99% | 0.00% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Yanchik Connealy Pamela | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 3488 | $0.00 | 3,488.0000 | 14,988,584 | 9999.99% | 0.02% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Yanchik Connealy Pamela | Director | A | Nonstatutory Stock Option (Right to Buy) | 18600 | $0.00 | 18,600.0000 | 14,988,584 | 9999.99% | 0.12% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Yanchik Connealy Pamela | Director | A | Nonstatutory Stock Option (Right to Buy) | 23250 | $0.00 | 23,250.0000 | 14,988,584 | 9999.99% | 0.16% |
| Jan. 3, 2023 | Pyxis Oncology, Inc. | $PYXS | Yanchik Connealy Pamela | Chief Financial Officer | A | Common Stock | 43493 | $0.00 | 384,510.0000 | 0 | 12.75% | 0.00% |